These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26825869)

  • 1. Reduced folate and serum vitamin metabolites in patients with rectal carcinoma: an open-label feasibility study of pemetrexed with folic acid and vitamin B12 supplementation.
    Stoffregen CC; Odin EA; Carlsson GU; Kurlberg GK; Björkqvist HG; Tångefjord MT; Gustavsson BG
    Anticancer Drugs; 2016 Jun; 27(5):439-46. PubMed ID: 26825869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of oral vitamin B12 supplementation as an alternative to intramuscular injection for patients with non-small cell lung cancer undergoing pemetrexed therapy.
    Takagi Y; Hosomi Y; Nagamata M; Watanabe K; Takahashi S; Nakahara Y; Yomota M; Sunami K; Okuma Y; Shimokawa T; Okamura T
    Cancer Chemother Pharmacol; 2016 Mar; 77(3):559-64. PubMed ID: 26821156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supplementation with vitamin B12 decreases homocysteine and methylmalonic acid but also serum folate in patients with end-stage renal disease.
    Dierkes J; Domröse U; Ambrosch A; Schneede J; Guttormsen AB; Neumann KH; Luley C
    Metabolism; 1999 May; 48(5):631-5. PubMed ID: 10337865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing of folic acid/vitamin B12 supplementation and hematologic toxicity during first-line treatment of patients with nonsquamous non-small cell lung cancer using pemetrexed-based chemotherapy: The PEMVITASTART randomized trial.
    Singh N; Baldi M; Kaur J; Muthu V; Prasad KT; Behera D; Bal A; Gupta N; Kapoor R
    Cancer; 2019 Jul; 125(13):2203-2212. PubMed ID: 30825389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and Design of PEMVITASTART-An Open-label Randomized Trial Comparing Simultaneous Versus Standard Initiation of Vitamin B
    Baldi M; Behera D; Kaur J; Kapoor R; Singh N
    Clin Lung Cancer; 2017 Jul; 18(4):432-435. PubMed ID: 28073680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of Same-Day Vitamin B12 Supplementation in Patients Receiving Pemetrexed for the Treatment of Non-Small-Cell Lung Cancer or Pleural Mesothelioma: A Retrospective Analysis.
    Schlei Z; Tan W; Faber MG; Chen H; Meagher A; Dy GK
    Clin Lung Cancer; 2018 Nov; 19(6):467-475. PubMed ID: 30369425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylenetetrahydrofolate reductase genotype, vitamin B12, and folate influence plasma homocysteine in hemodialysis patients.
    Nakamura T; Saionji K; Hiejima Y; Hirayama H; Tago K; Takano H; Tajiri M; Hayashi K; Kawabata M; Funamizu M; Makita Y; Hata A
    Am J Kidney Dis; 2002 May; 39(5):1032-9. PubMed ID: 11979347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase 1 dose de-escalation trial of the endogenous folate [6R]-5,10-methylene tetrahydrofolate in combination with fixed-dose pemetrexed as neoadjuvant therapy in patients with resectable rectal cancer.
    Gustavsson B; Carlsson G; Swartling T; Kurlberg G; Derwinger K; Björkqvist H; Odin E; Gibson F
    Invest New Drugs; 2015 Oct; 33(5):1078-85. PubMed ID: 26189513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.
    Azadibakhsh N; Hosseini RS; Atabak S; Nateghiyan N; Golestan B; Rad AH
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):779-88. PubMed ID: 19736473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A semimechanistic-physiologic population pharmacokinetic/pharmacodynamic model for neutropenia following pemetrexed therapy.
    Latz JE; Karlsson MO; Rusthoven JJ; Ghosh A; Johnson RD
    Cancer Chemother Pharmacol; 2006 Apr; 57(4):412-26. PubMed ID: 16322990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma.
    Scagliotti GV; Shin DM; Kindler HL; Vasconcelles MJ; Keppler U; Manegold C; Burris H; Gatzemeier U; Blatter J; Symanowski JT; Rusthoven JJ
    J Clin Oncol; 2003 Apr; 21(8):1556-61. PubMed ID: 12697881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of vitamin B(12), folate, and vitamin B(6) supplements in elderly people with normal serum vitamin B(12) concentrations.
    Henning BF; Tepel M; Riezler R; Naurath HJ
    Gerontology; 2001; 47(1):30-5. PubMed ID: 11244289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homocysteine, cystathionine, methylmalonic acid and B-vitamins in patients with renal disease.
    Herrmann W; Schorr H; Geisel J; Riegel W
    Clin Chem Lab Med; 2001 Aug; 39(8):739-46. PubMed ID: 11592444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective observational study of on-treatment plasma homocysteine levels as a biomarker of toxicity, depression and vitamin supplementation lead-in time pre pemetrexed, in patients with non-small cell lung cancer and malignant mesothelioma.
    Minchom A; Mak D; Gunapala R; Walder D; Kumar R; Yousaf N; Hodgkiss A; Bhosle J; Popat S; O'Brien MER
    PLoS One; 2019; 14(11):e0225509. PubMed ID: 31765437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma homocysteine levels and hematological toxicity in NSCLC patients after the first cycle of pemetrexed under folate supplementation.
    Tanaka H; Horiike A; Sakatani T; Saito R; Yanagitani N; Kudo K; Ohyanagi F; Horai T; Nishio M
    Anticancer Drugs; 2015 Jun; 26(5):573-8. PubMed ID: 25714250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine plasma levels in patients treated with antiepileptic drugs depend on folate and vitamin B12 serum levels, but not on genetic variants of homocysteine metabolism.
    Semmler A; Moskau-Hartmann S; Stoffel-Wagner B; Elger C; Linnebank M
    Clin Chem Lab Med; 2013 Mar; 51(3):665-9. PubMed ID: 23382314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I study of pemetrexed (LY231514) supplemented with folate and vitamin B12 in Japanese patients with solid tumours.
    Nakagawa K; Kudoh S; Matsui K; Negoro S; Yamamoto N; Latz JE; Adachi S; Fukuoka M
    Br J Cancer; 2006 Sep; 95(6):677-82. PubMed ID: 16940981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of plasma homocysteine and serum methylmalonate concentrations in apparently healthy elderly subjects after treatment with folic acid, vitamin B12 and vitamin B6: a randomised trial.
    Lewerin C; Nilsson-Ehle H; Matousek M; Lindstedt G; Steen B
    Eur J Clin Nutr; 2003 Nov; 57(11):1426-36. PubMed ID: 14576756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pemetrexed safety and dosing strategy.
    Niyikiza C; Hanauske AR; Rusthoven JJ; Calvert AH; Allen R; Paoletti P; Bunn PA
    Semin Oncol; 2002 Dec; 29(6 Suppl 18):24-9. PubMed ID: 12571807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folate, vitamin B12 and Homocysteine status in the post-folic acid fortification era in different subgroups of the Brazilian population attended to at a public health care center.
    Barnabé A; Aléssio AC; Bittar LF; de Moraes Mazetto B; Bicudo AM; de Paula EV; Höehr NF; Annichino-Bizzacchi JM
    Nutr J; 2015 Feb; 14():19. PubMed ID: 25886278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.